Curis stock has recently drawn increased attention following the latest round of analyst updates, with the consensus price target holding steady at $14.00 per share. While forecasts show little ...
Good afternoon, ladies and gentlemen, and welcome to the Curis Third Quarter 2025 Business Update Conference Call. [Operator Instructions] This call is being recorded on Thursday, November 6, 2025. I ...
Hosted on MSN
Curis Completes Sale of Erivedge Business
The latest update is out from Curis ( (CRIS)). On November 6, 2025, Curis completed the sale of its Erivedge Business to TPC Investments Royalty LLC, managed by Oberland, for $2.5 million and a ...
1. Curis Lifesciences IPO GMP: According to market sources, the latest grey market premium (GMP) of Curis Lifesciences IPO was ₹6. The latest GMP indicates the stock could be listed at a premium of 5 ...
LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Curis Inc. (CRIS) on Thursday reported a loss of $7.7 million in its third quarter. On a per-share basis, the Lexington, Massachusetts-based company ...
LEXINGTON, Mass., Nov. 6, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and ...
Gujarat-based pharma company Curis Lifesciences is set to tap capital markets with its initial public offering (IPO) next week on November 7. This would be the third public offer from the SME segment ...
LEXINGTON, Mass., Oct. 30, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 ...
Montserrat Oliver, the Mexican icon who started as an international model, has had a multifaceted career. After becoming a beloved TV personality, she decided to explore her creative side by jumping ...
LEXINGTON, Mass., Oct. 3, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 ...
We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Jennifer G. Sullivan ...
Hosted on MSN
Curis Files Prospectus Supplement for Stock Offering
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Curis ( (CRIS)) has provided an update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results